Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-04
1999-11-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, 514 14, 514 15, 514 16, 530317, 530327, 530328, 530329, A61K 3812, C07K 512
Patent
active
059814780
ABSTRACT:
This invention is directed to novel integrin binding peptides. These peptides bind to .alpha..sub.v - of .alpha..sub.5 -containing integrins and can exhibit high binding affinity. They contain one of the following sequence motifs: RX.sub.1 ETX.sub.2 WX.sub.3 [SEQ ID NO: 1] (especially RRETAWA [SEQ ID NO: 8]); RGDGX [SEQ ID NO: 2], in which X is an amino acid with a hydrophobic, aromatic side chain; the double cyclic CX.sub.1 CRGDCX.sub.2 C [SEQ ID NO: 15]; and RLD. The peptides generally exhibit their highest binding affinity when they assume a conformationally stabilized configuration. This invention also provides methods of using these peptides.
REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4957902 (1990-09-01), Grinnell
patent: 5091176 (1992-02-01), Braatz et al.
patent: 5110920 (1992-05-01), Erlich
patent: 5352667 (1994-10-01), Lider et al.
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5627263 (1997-05-01), Ruoslahti et al.
Koivunen et al. J. of Biological Chem, vol. 268, No. 27, pp. 20205-20210. Sep. 25, 1993.
Caplus on STN. No. 1993:186017. Fukuoka et al. Proc. Natl. Acad. Sci. U.S.A. 89(4). pp. 1189-1193, 1992.
O'Neil et al., "Identification of Novel Peptide Antagonist for GPIIb/IIIa from a Conformationally Constrained Phage Peptide Library", Proteins: Structure, Function, and Genetics, vol. 14 509-515, 1992.
Schulz et al., "Emprirical simialrtiies between amino acid residues", in Principles and Protein Structure, Springer-Verlag, New York 1979, pp. 14-16.
Fischer et al. "Inhibition of Osteoclastic Bone Resorption in Vivo by Echistatin an `Arginyl-Glycyl-Aspartyl` (RGD)-Containing Protien", Endocrinology, vol. 132, No. 3, pp. 1411-1413, 1993.
Brooks et al. "Requirement of Vascular Integrin Alpha V Beta 3 for Angiogenesis", Science, vol. 264, pp. 569-571, 1994.
Gehlsen et al. "Inhibition of Invitro Tumor Cell Invasion by Arg-Gly-Asp Containing Synthetic Peptides", J. of Cell Biol., vol. 106, pp. 925-930, 1988.
Humphries et al. "A Synthetic Peptide from Fibronectin Inhibits Experminetal Metastasis of Murine Melanoma Cells", Science, vol. 233, pp. 467-470, 1986.
Koivunen et al. Phage Libraties Displaying Cyclic Petides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins, Bio/Technology, vol. 13, pp. 265-270, 1995.
Koivunen et al., "Selection of Peptides Binding to the a5B1 Integrin form Phage Display Library." J. Biol. Chem. 268:20205-20210, Sep. 1993.
Peishoff et al., "Investigation of Conformational Specificity at GPIIb/IIIa: Evaluation of Confromationally Constrained RGD Peptides." J. Med. Chem. vol. 35, pp. 3962-3969, 1992.
Yamada, K. "Adehsive Recognition Sequences", J. of Biol. Chem., vol. 266, No. 2, pp. 12806-12812, Jul. 1991.
Rudinger, J. (1976). Peptide Hormones (ed. J.A. Parsons). University Park Press. Baltimore. pp. 1-7.
Koivunen et al., "Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins," Bio/Technology 13:265-270 (1995).
Samanen et al., "Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro," J. Med. Chem. 34:3114-3125 (1991).
Skubitz et al., "Synthetic Peptides from the Carboxy-terminal Globular Domain of the A Chain of Laminin: Their Ability to Promote Cell Adhesion and Neurite Outgrowth, and Interact with Heparin and the .beta.1 Integrin Subunit," J. Cell Biol. 115:1137-1148 (1991).
Koivunen Erkki
Ruoslahti Erkki
Gupta Anish
La Jolla Cancer Research Foundation
Tsang Cecilia J.
LandOfFree
Integrin-binding peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrin-binding peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin-binding peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455956